Madrigal Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US5588681057

SecurityMDGL / Madrigal Pharmaceuticals, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership52,884 shares
Latest Disclosed Value $ 27,683,187
Squarepoint Ops LLC ownership in MDGL / Madrigal Pharmaceuticals, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 52,884 shares of Madrigal Pharmaceuticals, Inc. (US:MDGL) valued at $27,683,187 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 74,934 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -29.43% during the quarter. The current value of the position is $25,815,325 USD.

Squarepoint Ops LLC has a history of taking positions in derivatives of the underlying security (MDGL) in the form of stock options. The firm currently holds call options representing 12,700 of underlying shares valued at $6,648,069 USD and put options representing 4,500 of underlying shares valued at $2,355,615 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MDGL / Madrigal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 52,884 -22,050 -29.43 27,683 -36.56 0.0325
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 74,934 44,998 150.31 43,637 217.82 0.0464
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 29,936 25,554 583.16 13,730 935.44 0.0138
2025-08-27 2025-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 4,382 2,734 165.90 1,326 143.30 0.0014
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 4,382 2,734 1,326 0.0014
2025-08-27 2025-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 1,648 100 6.46 546 14.26 0.0007
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,648 100 546 0.0007
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,548 1,548 478 0.0005
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -5,170 -100.00 0 -100.00
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,170 5,170 1,448 0.0024
2023-05-15 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -2,932 -100.00 0 -100.00
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,932 2,932 851 0.0034
2022-11-14 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -4,074 -100.00 0 -100.00
2022-08-15 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 4,074 4,074 292 0.0016
2022-05-16 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -22,827 -100.00 0 -100.00
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 22,827 -12,288 -34.99 1,934 -30.98 0.0051
2021-11-15 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 35,115 2,528 7.76 2,802 -11.72 0.0080
2021-08-16 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 32,587 13,123 67.42 3,174 39.39 0.0121
2021-05-17 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 19,464 16,352 525.45 2,277 558.09 0.0133
2021-02-16 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,112 -1,641 -34.53 346 -38.65 0.0026
2020-11-16 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 4,753 1,763 58.96 564 66.37 0.0076
2020-08-14 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,990 2,990 339 0.0055
2020-05-15 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -21,301 -100.00 0 -100.00
2020-02-14 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 21,301 17,409 447.30 1,941 477.68 0.0115
2019-11-14 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,892 3,892 336 0.0030
2019-08-14 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -2,300 -100.00 0 -100.00
2019-05-15 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,300 -172 -6.96 288 3.23 0.0030
2019-02-14 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 2,472 -1,579 -38.98 279 -67.82 0.0032
2018-11-14 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 4,051 2,451 153.19 867 93.53 0.0104
2018-08-14 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,600 -2,192 -57.81 448 1.13 0.0059
2018-05-15 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,792 -133 -3.39 443 23.06 0.0070
2018-02-14 2017-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,925 3,925 360 0.0063
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 12,700 1,054.55 6,648 938.75 n/a n/a n/a
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 1,100 -78.00 641 -72.09 n/a n/a n/a
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 5,000 72.41 2,293 161.46 n/a n/a n/a
2025-08-27 2025-06-30 13F/A MADRIGAL PHARMACEUTICALS COM Call 2,900 38.10 878 26.19 n/a n/a n/a
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 2,900 878 n/a n/a n/a
2025-08-27 2025-03-31 13F/A MADRIGAL PHARMACEUTICALS COM Call 2,100 -89.90 696 -89.17 n/a n/a n/a
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 2,100 696 n/a n/a n/a
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Call 20,800 6,418 n/a n/a n/a
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Call 15,000 0.00 4,202 4.92 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Call 15,000 4,006 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 4,500 -22.41 2,356 -30.26 n/a n/a n/a
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 5,800 -63.75 3,378 -53.98 n/a n/a n/a
2025-11-14 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 16,000 46.79 7,339 122.50 n/a n/a n/a
2025-08-27 2025-06-30 13F/A MADRIGAL PHARMACEUTICALS COM Put 10,900 29.76 3,299 18.55 n/a n/a n/a
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 10,900 3,299 n/a n/a n/a
2025-08-27 2025-03-31 13F/A MADRIGAL PHARMACEUTICALS COM Put 8,400 -50.59 2,782 -46.96 n/a n/a n/a
2025-05-15 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 8,400 2,782 n/a n/a n/a
2025-02-14 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM Put 17,000 5,246 n/a n/a n/a
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM Put 15,000 0.00 4,202 4.92 n/a n/a n/a
2024-05-15 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM Put 15,000 4,006 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.